{"ticker":"RVMD","companyName":"Revolution Medicines, Inc.","fiscalYear":2024,"executiveName":"Mark A. Goldsmith","executiveTitle":"President and Chief Executive Officer","totalComp":10079491,"salary":689167,"stockAwards":2682000,"optionAwards":6049524,"nonEquityIncentive":651800,"otherComp":7000,"yoyChangePct":-3.186515505779471,"source":{"filingType":"DEF 14A","filingDate":"2025-04-29","filingUrl":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm"},"lastUpdated":"2026-04-15T07:25:16.790Z"}